Caffeine Study for Pain Control Following Total Joint Replacement
NCT ID: NCT04280263
Last Updated: 2020-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2020-02-28
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Pain Treatment in Total Hip Arthroplasty: A Study to Assess the Effect of Local Analgesia
NCT00603083
The Role of Intra-Operative Intracapsular Blocks in Post-Operative Pain Management Following Total Knee Arthroplasty
NCT00620828
Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Replacement
NCT03119038
Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty
NCT02570503
A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics
NCT01534286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Caffiene
This group will receive 150mg caffeine tablets to be taken twice per day
Caffeine
caffeine tables containing 150mg caffeine will be provided to patients with instructions to take twice per day
placebo
Placebo oral tablet
oral placebo tablets matching the caffeine tablets and will be provided to patients with instructions to take twice per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Caffeine
caffeine tables containing 150mg caffeine will be provided to patients with instructions to take twice per day
Placebo oral tablet
oral placebo tablets matching the caffeine tablets and will be provided to patients with instructions to take twice per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is treated by Rothman Orthopaedics institute and is scheduled for the surgical procedure at AtlantiCare Regional Medical Center.
* Patient is undergoing total hip or total knee arthroplasty.
* Patient has the diagnosis of Osteoarthritis of the hip or the knee, or other noninflammatory disease that results in joint damage to the hip or the knee.
Exclusion Criteria
* Patient has history of cardiac diseases that might be aggravated by the use of caffeine, as diagnosed by a cardiologist or demonstrated by an abnormal EKG.
* Patient has a known allergy to aspirin or caffeine.
* Patient has history of chronic pain that required the intervention of a pain management doctor.
* Patient has an active infection at the time of surgery (systemic or localized) or history of chronic infections that affected the lower extremities.
* Patient has history of cancer that would affect patient reported outcomes including pain.
* Patient has history of neuropathic pain or nerve degenerative disease.
* Patients undergoing revision surgery would be excluded.
* Patients who require alternate DTV prophylaxis other than ASA.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rothman Institute Orthopaedics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rothman Orthopaedics at Egg Harbor Township
Egg Harbor, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020 DP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.